Posts
$IBIO: Why I'm watching this $70M biotech - Short % rising, volume waking up, resistance $1.70-$1.90
Ticker: $IBIO - iBio Inc Price: \~$1.35 | Market Cap: \~$70M | 52W: $0.56 - $3.82 TLDR: 7.78% of float short, DTC 4.8 days, short interest +10.31% MoM. Interesting micro-cap setup, but NOT a squeeze yet. High risk biotech. 1. What is it? iBio is a pre-clinical AI biotech focused …
$VPRB signs $11M patent licensing deal with JUUL — days after $14.9M R.J. Reynolds deal
VPR Brands ($VPRB) just filed an 8-K announcing an **$11 million License and Release Agreement with JUUL Labs** involving its ‘622 vaping patent and other patent claims. This comes right after VPRB announced a separate **$14.9 million settlement/license agreement with R.J. Reynolds Vapor**. That’s now **$25.9 million in disclosed deal …
Management is executing on a district-scale vision, far beyond simple drilling holes.
Juniors mostly do same thing all over. Raise some cash. Pick one target. Drill it. Hope for a hit. If they miss they either die or dilute shareholders to try again. Its a one hole lottery ticket and most tickets lose. NRED is doing the complete opposite. Look at what …
VisionWave CEO just met with Meteor Aerospace in Israel!
VisionWave (Nasdaq: VWAV) put out news today that their leadership team was in Israel doing integration meetings with Meteor Aerospace. This is for the 51% acquisition deal they announced back in June. They’re reviewing the Meteor’s deal, drones, ground vehicles, electronic warfare systems, etc, and starting to plan how everything …
SPRO Spero Therapeutics FDA approval and then drops? Cheaper buyout?
https://preview.redd.it/tdwnmd3eyzeh1.png?width=2067&format=png&auto=webp&s=09d9e60684600225abc3819ba8746001b85b5230 Picked up 11,000 shares at 2.27$ after the news about their FDA approval for Utebzi (tebipenem pivoxil) — Oral antibiotic for complicated urinary tract infections (cUTIs), including pyelonephritis, in adults. Commercialized via GSK partnership. This was a major catalyst and should have double the price but instead it did …
$SWRD Micro float AI lending company pursuing Nasdaq uplisting
Came across SWRD and figured I’d share a few things that caught my attention. AI-powered commercial/business lending platform. Company is pursuing a Nasdaq uplisting. The stock traded above **$4**, an important price threshold for many Nasdaq initial listing standards, assuming the company meets the other listing requirements. According to the …
$ANNA (AleAnna) - Italian Natural Gas Play
Been looking at AleAnna. Small company with onshore natural gas production in Italy. Had a strong move earlier this year directly after the breakout if the Iran war. Recent 8-K showed higher LNG concentrations than expected. Relatively high insider ownership. The stock has low float, it can be volatile and …
(SWISF) Sekur Private Data Report
(SWISF) (SKUR.CN) Sekur Private Data is a Swiss-hosted encrypted communications company (CSE: SKUR / OTCQB: SWISF) repositioning from consumer privacy products toward government and defense secure communications, built on its proprietary post-quantum HeliX® encryption architecture. •Between October 2025 and July 2026, the company appointed John T. Lewis, a 34-year CIA …
AI Slop Machine - Full Port
OK. I've gone through everything. The actual data. Let me give you a real answer. \--- POWW. Here's the thesis in plain terms: [GunBroker.com](http://GunBroker.com) is literally eBay for guns. The ammo business got sold to Olin Winchester for $75M in April 2025 and what's left is a pure marketplace — …
MVMDF: A Peptides Play
On July 23-24, an advisory committee called PCAC will vote whether to recommend that any of seven peptides be approved by the FDA for pharmaceutical compounding (see [here](https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026) for meeting notes). Many of those peptides, particularly BPC-157, are already used widely and available on the grey market. Were the FDA …